Date | Dividends Paid | Capital Expenditure | Other Financing Activities | Net Cash Used Provided By Financing Activities |
---|
CEO | Mr. Jeffrey N. Simmons |
IPO Date | Sept. 20, 2018 |
Location | United States |
Headquarters | 2500 Innovation Way |
Employees | 9,300 |
Sector | Consumers Staples |
Industries |
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Past 5 years
USD 127.08
USD 1.79
USD 5.98
USD 2.34
USD 31.53
USD 26.33
USD 92.51
USD 76.77
USD 21.81
USD 11.28
USD 32.12
StockViz Staff
February 2, 2025
Any question? Send us an email